Olaf Burkhardt
Impact in
-
- Antibiotic Use and Resistance
- Molecular Medicine top 1%
- Antibiotic Resistance in Bacteria
Papers in
- Pharmacology 25
- Antibiotics Pharmacokinetics and Efficacy 25
- Epidemiology 21
- Pneumonia and Respiratory Infections 10
- Sepsis Diagnosis and Treatment 6
- Co-authors
- Tobias Welte (27 shared papers)Hartmut Derendorf (9 shared papers)Mathias W. Pletz (11 shared papers)H. Lode (9 shared papers)Stephan Schmidt (4 shared papers)A de Roux (4 shared papers)Jan T. Kielstein (8 shared papers)Volkhard Kaever (5 shared papers)
- Journals
- Journal of Antimicrobial Chemotherapy (5 papers)Antimicrobial Agents and Chemotherapy (4 papers)Nephrology Dialysis Transplantation (3 papers)European Respiratory Journal (3 papers)Clinical Infectious Diseases (3 papers)
- Partner nations
- GermanyUnited StatesSwitzerland
In The Last Decade
Olaf Burkhardt
55 papers receiving 2.1k citations
Peers
Comparison fields: 5 of 103
- Applied Microbiology and Biotechnology 178
- Molecular Medicine 292
- Critical Care and Intensive Care Medicine 172
- Pharmacology 628
- Epidemiology 796
Countries citing papers authored by Olaf Burkhardt
This map shows the geographic impact of Olaf Burkhardt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Olaf Burkhardt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Olaf Burkhardt more than expected).
Fields of papers citing papers by Olaf Burkhardt
This network shows the impact of papers produced by Olaf Burkhardt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Olaf Burkhardt. The network helps show where Olaf Burkhardt may publish in the future.
Co-authors
The 25 scholars most cited alongside Olaf Burkhardt, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 56 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 199 | |
| 2 | 2012 | 183 | |
| 3 | 2009 | 122 | |
| 4 | 2010 | 117 | |
| 5 | 2004 | 95 | |
| 6 | 2006 | 94 | |
| 7 | 2008 | 89 | |
| 8 | 2006 | 78 | |
| 9 | 2013 | 72 | |
| 10 | 2009 | 63 | |
| 11 | 2009 | 61 | |
| 12 | 2009 | 52 | |
| 13 | 2008 | 50 | |
| 14 | 2004 | 49 | |
| 15 | 2006 | 49 | |
| 16 | 2010 | 46 | |
| 17 | 2011 | 46 | |
| 18 | 2005 | 42 | |
| 19 | 2015 | 40 | |
| 20 | 2007 | 38 |
About Olaf Burkhardt
Olaf Burkhardt is a scholar working on Pharmacology, Epidemiology, Molecular Medicine, Infectious Diseases and Pulmonary and Respiratory Medicine, having authored 56 papers that have together received 2.1k indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (25 papers), Antibiotic Resistance in Bacteria (12 papers), Pneumonia and Respiratory Infections (10 papers), Antimicrobial Resistance in Staphylococcus (7 papers), Sepsis Diagnosis and Treatment (6 papers), Bacterial Identification and Susceptibility Testing (6 papers), Antifungal resistance and susceptibility (4 papers) and Antibiotic Use and Resistance (3 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (178 citations), Molecular Medicine (292 citations), Critical Care and Intensive Care Medicine (172 citations), Pharmacology (628 citations) and Epidemiology (796 citations). Olaf Burkhardt has collaborated with scholars based in Germany, United States and Switzerland. Frequent co-authors include Tobias Welte, Hartmut Derendorf, Mathias W. Pletz, H. Lode, Stephan Schmidt, A de Roux, Jan T. Kielstein, Volkhard Kaever, Vipul Kumar and Bernd Drewelow. Their work appears in journals such as Journal of Antimicrobial Chemotherapy, Antimicrobial Agents and Chemotherapy, Nephrology Dialysis Transplantation, European Respiratory Journal and Clinical Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.